Fig. 2From: Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery diseasePlasma levels of glucose (a), C-peptide (b), insulin (c), insulin secretion rates (d), glucagon (e) and NEFA (f) during meal testBack to article page